Statement on combined hormonal contraceptives containing third-or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism

Johannes Bitzer, Jean Jacques Amy, Rob Beerthuizen, Martin Birkhäuser, Teresa Bombas, Mitchell Creinin, Philip D. Darney, Lisa Ferreira Vicente, Kristina Gemzell-Danielsson, Bruno Imthurn, Jeffrey T. Jensen, Andrew M. Kaunitz, Ali Kubba, Medard M. Lech, Diana Mansour, Gabriele Merki, Thomas Rabe, Katarina Sedlecki, David Serfaty, Jacques SeydouxLee P. Shulman, Regine Sitruk-Ware, Sven O. Skouby, Anne Szarewski, James Trussell, Carolyn Westhoff

Research output: Contribution to journalArticle

12 Scopus citations
Original languageEnglish (US)
Pages (from-to)143-147
Number of pages5
JournalEuropean Journal of Contraception and Reproductive Health Care
Volume18
Issue number3
DOIs
StatePublished - Jun 2013

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology
  • Pharmacology (medical)

Cite this

Bitzer, J., Amy, J. J., Beerthuizen, R., Birkhäuser, M., Bombas, T., Creinin, M., Darney, P. D., Vicente, L. F., Gemzell-Danielsson, K., Imthurn, B., Jensen, J. T., Kaunitz, A. M., Kubba, A., Lech, M. M., Mansour, D., Merki, G., Rabe, T., Sedlecki, K., Serfaty, D., ... Westhoff, C. (2013). Statement on combined hormonal contraceptives containing third-or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism. European Journal of Contraception and Reproductive Health Care, 18(3), 143-147. https://doi.org/10.3109/13625187.2013.792637